Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis

What is the purpose of this trial?

The purpose of this study is to evaluate the safety and efficacy of roxadustat compare to epoetin alfa for the treatment of anemia in chronic kidney disease patients on dialysis.


Participation Guidelines

Ages: 18 years and older

Gender: Both


Astra Zeneca, L.P.

Dates: 08/04/2015 - 09/30/2019

Last Updated: 12/10/2017

Study HIC#: 1502015388

Get Involved

For more information about this study, contact:
Lauren Liberti
+1 203-737-8010
lauren.liberti@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Neera Kanhouwa Dahl

Principal Investigator

Sub-Investigators